Bioadaptives annual return on equity
2014
Bioadaptives Return on Equity (ROE) Growth & History (BDPT)
Bioadaptives's return on equity was −5,829.87% for fiscal 2014.
View full Bioadaptives company overviewBioadaptives annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2014 | 2014-12-31 | −5,829.87% | — |
Bioadaptives quarterly return on equity
Q1.14
Q2.14
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2014 | 2014-06-30 | −286.00% | — |
| Q1 2014 | 2014-03-31 | −6.75% | — |
Bioadaptives return on equity trends
The latest reported quarter, Q2 2014, shows −286.00%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioadaptives source filings ↗